Notably, targeted attenuation of PAICS robustly curtailed the proliferative propensity and growth dynamics of EGFR wild‐type NSCLC cellular models, both in vitro assays and in vivo murine xenograft frameworks. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.